ANI Pharmaceuticals (ANIP) announced that the company has initiated closing logistics for the previously announced acquisition of Alimera Sciences (ALIM). The company expects closing of the acquisition of Alimera Sciences to be consummated and announced on September 16, pending satisfaction or waiver of any remaining customary closing conditions.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANIP:
- ANI Pharmaceuticals launches Promethazine Hydrochloride
- ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution
- Salesforce downgraded, Charter upgraded: Wall Street’s top analyst calls
- ANI Pharmaceuticals, Alimera Sciences merger to close on September 16
- ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger